Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences.
Yoga WaranugrahaArdian RizalMokhamad Fahmi Rizki SyabanIcha Farihah Deniyati FaratishaNabila Erina ErwanKhadijah Cahya YunitaPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2021)
In NVAF patients, NOACs were found to be more effective than warfarin at reducing stroke risk. NOACSs also lowered the risk of all-cause mortality, cerebral hemorrhage, and severe bleeding in NVAF patients compared to warfarin.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- direct oral anticoagulants
- left atrial appendage
- end stage renal disease
- ejection fraction
- venous thromboembolism
- heart failure
- newly diagnosed
- prognostic factors
- percutaneous coronary intervention
- peritoneal dialysis
- mitral valve
- patient reported